世界のエクソソーム診断・治療市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Exosome Diagnostics and Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A11767 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：産業機械＆装置

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、エクソソーム診断・治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。エクソソーム診断・治療の種類別市場規模（機器、試薬、ソフトウェア）、用途別市場規模（診断、治療）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・エクソソーム診断・治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Aethlon Medical(US)、Exosome Diagnostics(US)、NanoSomix Inc.(US)、Thermo Fisher Scientific (US)、Malvern Instruments (UK)、System Biosciences(US)、NX Pharmagen (US)、Sistemic Inc(UK)、Capricor Therapeutics (US)、Exiqon A/S (Denmark) ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：機器、試薬、ソフトウェア ・用途別分析2016年-2026年：診断、治療 ・エクソソーム診断・治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・エクソソーム診断・治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・エクソソーム診断・治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・エクソソーム診断・治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・エクソソーム診断・治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Exosome Diagnostics and Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Exosome Diagnostics and Therapeutics size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Exosome Diagnostics and Therapeutics market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Exosome Diagnostics and Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Instrument
Reagent
Software

Market segment by Application, can be divided into
Diagnostic
Therapeutic

Market segment by players, this report covers
Aethlon Medical(US)
Exosome Diagnostics(US)
NanoSomix Inc.(US)
Thermo Fisher Scientific (US)
Malvern Instruments (UK)
System Biosciences(US)
NX Pharmagen (US)
Sistemic Inc(UK)
Capricor Therapeutics (US)
Exiqon A/S (Denmark)

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Exosome Diagnostics and Therapeutics
1.2 Classification of Exosome Diagnostics and Therapeutics by Type
1.2.1 Overview: Global Exosome Diagnostics and Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Exosome Diagnostics and Therapeutics Revenue Market Share by Type in 2020
1.2.3 Instrument
1.2.4 Reagent
1.2.5 Software
1.3 Global Exosome Diagnostics and Therapeutics Market by Application
1.3.1 Overview: Global Exosome Diagnostics and Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Diagnostic
1.3.3 Therapeutic
1.4 Global Exosome Diagnostics and Therapeutics Market Size & Forecast
1.5 Global Exosome Diagnostics and Therapeutics Market Size and Forecast by Region
1.5.1 Global Exosome Diagnostics and Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Exosome Diagnostics and Therapeutics Market Size by Region, (2016-2021)
1.5.3 North America Exosome Diagnostics and Therapeutics Market Size and Prospect (2016-2026)
1.5.4 Europe Exosome Diagnostics and Therapeutics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size and Prospect (2016-2026)
1.5.6 South America Exosome Diagnostics and Therapeutics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Exosome Diagnostics and Therapeutics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Exosome Diagnostics and Therapeutics Market Drivers
1.6.2 Exosome Diagnostics and Therapeutics Market Restraints
1.6.3 Exosome Diagnostics and Therapeutics Trends Analysis
2 Company Profiles
2.1 Aethlon Medical(US)
2.1.1 Aethlon Medical(US) Details
2.1.2 Aethlon Medical(US) Major Business
2.1.3 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Product and Solutions
2.1.4 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Aethlon Medical(US) Recent Developments and Future Plans
2.2 Exosome Diagnostics(US)
2.2.1 Exosome Diagnostics(US) Details
2.2.2 Exosome Diagnostics(US) Major Business
2.2.3 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Product and Solutions
2.2.4 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Exosome Diagnostics(US) Recent Developments and Future Plans
2.3 NanoSomix Inc.(US)
2.3.1 NanoSomix Inc.(US) Details
2.3.2 NanoSomix Inc.(US) Major Business
2.3.3 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Product and Solutions
2.3.4 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 NanoSomix Inc.(US) Recent Developments and Future Plans
2.4 Thermo Fisher Scientific (US)
2.4.1 Thermo Fisher Scientific (US) Details
2.4.2 Thermo Fisher Scientific (US) Major Business
2.4.3 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Product and Solutions
2.4.4 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Thermo Fisher Scientific (US) Recent Developments and Future Plans
2.5 Malvern Instruments (UK)
2.5.1 Malvern Instruments (UK) Details
2.5.2 Malvern Instruments (UK) Major Business
2.5.3 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Product and Solutions
2.5.4 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Malvern Instruments (UK) Recent Developments and Future Plans
2.6 System Biosciences(US)
2.6.1 System Biosciences(US) Details
2.6.2 System Biosciences(US) Major Business
2.6.3 System Biosciences(US) Exosome Diagnostics and Therapeutics Product and Solutions
2.6.4 System Biosciences(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 System Biosciences(US) Recent Developments and Future Plans
2.7 NX Pharmagen (US)
2.7.1 NX Pharmagen (US) Details
2.7.2 NX Pharmagen (US) Major Business
2.7.3 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Product and Solutions
2.7.4 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 NX Pharmagen (US) Recent Developments and Future Plans
2.8 Sistemic Inc(UK)
2.8.1 Sistemic Inc(UK) Details
2.8.2 Sistemic Inc(UK) Major Business
2.8.3 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Product and Solutions
2.8.4 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Sistemic Inc(UK) Recent Developments and Future Plans
2.9 Capricor Therapeutics (US)
2.9.1 Capricor Therapeutics (US) Details
2.9.2 Capricor Therapeutics (US) Major Business
2.9.3 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Product and Solutions
2.9.4 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Capricor Therapeutics (US) Recent Developments and Future Plans
2.10 Exiqon A/S (Denmark)
2.10.1 Exiqon A/S (Denmark) Details
2.10.2 Exiqon A/S (Denmark) Major Business
2.10.3 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Product and Solutions
2.10.4 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Exiqon A/S (Denmark) Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Exosome Diagnostics and Therapeutics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Exosome Diagnostics and Therapeutics Players Market Share
3.2.2 Top 10 Exosome Diagnostics and Therapeutics Players Market Share
3.2.3 Market Competition Trend
3.3 Exosome Diagnostics and Therapeutics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Exosome Diagnostics and Therapeutics Revenue and Market Share by Type (2016-2021)
4.2 Global Exosome Diagnostics and Therapeutics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Exosome Diagnostics and Therapeutics Revenue Market Share by Application (2016-2021)
5.2 Exosome Diagnostics and Therapeutics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Exosome Diagnostics and Therapeutics Revenue by Type (2016-2026)
6.2 North America Exosome Diagnostics and Therapeutics Revenue by Application (2016-2026)
6.3 North America Exosome Diagnostics and Therapeutics Market Size by Country
6.3.1 North America Exosome Diagnostics and Therapeutics Revenue by Country (2016-2026)
6.3.2 United States Exosome Diagnostics and Therapeutics Market Size and Forecast (2016-2026)
6.3.3 Canada Exosome Diagnostics and Therapeutics Market Size and Forecast (2016-2026)
6.3.4 Mexico Exosome Diagnostics and Therapeutics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Exosome Diagnostics and Therapeutics Revenue by Type (2016-2026)
7.2 Europe Exosome Diagnostics and Therapeutics Revenue by Application (2016-2026)
7.3 Europe Exosome Diagnostics and Therapeutics Market Size by Country
7.3.1 Europe Exosome Diagnostics and Therapeutics Revenue by Country (2016-2026)
7.3.2 Germany Exosome Diagnostics and Therapeutics Market Size and Forecast (2016-2026)
7.3.3 France Exosome Diagnostics and Therapeutics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Exosome Diagnostics and Therapeutics Market Size and Forecast (2016-2026)
7.3.5 Russia Exosome Diagnostics and Therapeutics Market Size and Forecast (2016-2026)
7.3.6 Italy Exosome Diagnostics and Therapeutics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Exosome Diagnostics and Therapeutics Revenue by Type (2016-2026)
8.2 Asia-Pacific Exosome Diagnostics and Therapeutics Revenue by Application (2016-2026)
8.3 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Region
8.3.1 Asia-Pacific Exosome Diagnostics and Therapeutics Revenue by Region (2016-2026)
8.3.2 China Exosome Diagnostics and Therapeutics Market Size and Forecast (2016-2026)
8.3.3 Japan Exosome Diagnostics and Therapeutics Market Size and Forecast (2016-2026)
8.3.4 South Korea Exosome Diagnostics and Therapeutics Market Size and Forecast (2016-2026)
8.3.5 India Exosome Diagnostics and Therapeutics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Exosome Diagnostics and Therapeutics Market Size and Forecast (2016-2026)
8.3.7 Australia Exosome Diagnostics and Therapeutics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Exosome Diagnostics and Therapeutics Revenue by Type (2016-2026)
9.2 South America Exosome Diagnostics and Therapeutics Revenue by Application (2016-2026)
9.3 South America Exosome Diagnostics and Therapeutics Market Size by Country
9.3.1 South America Exosome Diagnostics and Therapeutics Revenue by Country (2016-2026)
9.3.2 Brazil Exosome Diagnostics and Therapeutics Market Size and Forecast (2016-2026)
9.3.3 Argentina Exosome Diagnostics and Therapeutics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Exosome Diagnostics and Therapeutics Revenue by Type (2016-2026)
10.2 Middle East & Africa Exosome Diagnostics and Therapeutics Revenue by Application (2016-2026)
10.3 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Country
10.3.1 Middle East & Africa Exosome Diagnostics and Therapeutics Revenue by Country (2016-2026)
10.3.2 Turkey Exosome Diagnostics and Therapeutics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Exosome Diagnostics and Therapeutics Market Size and Forecast (2016-2026)
10.3.4 UAE Exosome Diagnostics and Therapeutics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Exosome Diagnostics and Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Exosome Diagnostics and Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Exosome Diagnostics and Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Exosome Diagnostics and Therapeutics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Region (2021-2026)
Table 6. Aethlon Medical(US) Corporate Information, Head Office, and Major Competitors
Table 7. Aethlon Medical(US) Major Business
Table 8. Aethlon Medical(US) Exosome Diagnostics and Therapeutics Product and Solutions
Table 9. Aethlon Medical(US) Exosome Diagnostics and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Exosome Diagnostics(US) Corporate Information, Head Office, and Major Competitors
Table 11. Exosome Diagnostics(US) Major Business
Table 12. Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Product and Solutions
Table 13. Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. NanoSomix Inc.(US) Corporate Information, Head Office, and Major Competitors
Table 15. NanoSomix Inc.(US) Major Business
Table 16. NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Product and Solutions
Table 17. NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Thermo Fisher Scientific (US) Corporate Information, Head Office, and Major Competitors
Table 19. Thermo Fisher Scientific (US) Major Business
Table 20. Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Product and Solutions
Table 21. Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Malvern Instruments (UK) Corporate Information, Head Office, and Major Competitors
Table 23. Malvern Instruments (UK) Major Business
Table 24. Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Product and Solutions
Table 25. Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. System Biosciences(US) Corporate Information, Head Office, and Major Competitors
Table 27. System Biosciences(US) Major Business
Table 28. System Biosciences(US) Exosome Diagnostics and Therapeutics Product and Solutions
Table 29. System Biosciences(US) Exosome Diagnostics and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. NX Pharmagen (US) Corporate Information, Head Office, and Major Competitors
Table 31. NX Pharmagen (US) Major Business
Table 32. NX Pharmagen (US) Exosome Diagnostics and Therapeutics Product and Solutions
Table 33. NX Pharmagen (US) Exosome Diagnostics and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Sistemic Inc(UK) Corporate Information, Head Office, and Major Competitors
Table 35. Sistemic Inc(UK) Major Business
Table 36. Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Product and Solutions
Table 37. Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Capricor Therapeutics (US) Corporate Information, Head Office, and Major Competitors
Table 39. Capricor Therapeutics (US) Major Business
Table 40. Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Product and Solutions
Table 41. Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Exiqon A/S (Denmark) Corporate Information, Head Office, and Major Competitors
Table 43. Exiqon A/S (Denmark) Major Business
Table 44. Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Product and Solutions
Table 45. Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Exosome Diagnostics and Therapeutics Revenue (USD Million) by Players (2019-2021)
Table 47. Global Exosome Diagnostics and Therapeutics Revenue Share by Players (2019-2021)
Table 48. Breakdown of Exosome Diagnostics and Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Exosome Diagnostics and Therapeutics Players Head Office, Products and Services Provided
Table 50. Exosome Diagnostics and Therapeutics Mergers & Acquisitions in the Past Five Years
Table 51. Exosome Diagnostics and Therapeutics New Entrants and Expansion Plans
Table 52. Global Exosome Diagnostics and Therapeutics Revenue (USD Million) by Type (2016-2021)
Table 53. Global Exosome Diagnostics and Therapeutics Revenue Share by Type (2016-2021)
Table 54. Global Exosome Diagnostics and Therapeutics Revenue Forecast by Type (2021-2026)
Table 55. Global Exosome Diagnostics and Therapeutics Revenue by Application (2016-2021)
Table 56. Global Exosome Diagnostics and Therapeutics Revenue Forecast by Application (2021-2026)
Table 57. North America Exosome Diagnostics and Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Exosome Diagnostics and Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Exosome Diagnostics and Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Exosome Diagnostics and Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Exosome Diagnostics and Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Exosome Diagnostics and Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Exosome Diagnostics and Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Exosome Diagnostics and Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Exosome Diagnostics and Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Exosome Diagnostics and Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Exosome Diagnostics and Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Exosome Diagnostics and Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Exosome Diagnostics and Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Exosome Diagnostics and Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Exosome Diagnostics and Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Exosome Diagnostics and Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Exosome Diagnostics and Therapeutics Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Exosome Diagnostics and Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Exosome Diagnostics and Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Exosome Diagnostics and Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Exosome Diagnostics and Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Exosome Diagnostics and Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Exosome Diagnostics and Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Exosome Diagnostics and Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Exosome Diagnostics and Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Exosome Diagnostics and Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Exosome Diagnostics and Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Exosome Diagnostics and Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Exosome Diagnostics and Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Exosome Diagnostics and Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Exosome Diagnostics and Therapeutics Picture
Figure 2. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Type in 2020
Figure 3. Instrument
Figure 4. Reagent
Figure 5. Software
Figure 6. Exosome Diagnostics and Therapeutics Revenue Market Share by Application in 2020
Figure 7. Diagnostic Picture
Figure 8. Therapeutic Picture
Figure 9. Global Exosome Diagnostics and Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Exosome Diagnostics and Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Region (2016-2026)
Figure 12. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Region in 2020
Figure 13. North America Exosome Diagnostics and Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Exosome Diagnostics and Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Exosome Diagnostics and Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Exosome Diagnostics and Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Exosome Diagnostics and Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Exosome Diagnostics and Therapeutics Market Drivers
Figure 19. Exosome Diagnostics and Therapeutics Market Restraints
Figure 20. Exosome Diagnostics and Therapeutics Market Trends
Figure 21. Aethlon Medical(US) Recent Developments and Future Plans
Figure 22. Exosome Diagnostics(US) Recent Developments and Future Plans
Figure 23. NanoSomix Inc.(US) Recent Developments and Future Plans
Figure 24. Thermo Fisher Scientific (US) Recent Developments and Future Plans
Figure 25. Malvern Instruments (UK) Recent Developments and Future Plans
Figure 26. System Biosciences(US) Recent Developments and Future Plans
Figure 27. NX Pharmagen (US) Recent Developments and Future Plans
Figure 28. Sistemic Inc(UK) Recent Developments and Future Plans
Figure 29. Capricor Therapeutics (US) Recent Developments and Future Plans
Figure 30. Exiqon A/S (Denmark) Recent Developments and Future Plans
Figure 31. Global Exosome Diagnostics and Therapeutics Revenue Share by Players in 2020
Figure 32. Exosome Diagnostics and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 33. Global Top 3 Players Exosome Diagnostics and Therapeutics Revenue Market Share in 2020
Figure 34. Global Top 10 Players Exosome Diagnostics and Therapeutics Revenue Market Share in 2020
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 36. Global Exosome Diagnostics and Therapeutics Revenue Share by Type in 2020
Figure 37. Global Exosome Diagnostics and Therapeutics Market Share Forecast by Type (2021-2026)
Figure 38. Global Exosome Diagnostics and Therapeutics Revenue Share by Application in 2020
Figure 39. Global Exosome Diagnostics and Therapeutics Market Share Forecast by Application (2021-2026)
Figure 40. North America Exosome Diagnostics and Therapeutics Sales Market Share by Type (2016-2026)
Figure 41. North America Exosome Diagnostics and Therapeutics Sales Market Share by Application (2016-2026)
Figure 42. North America Exosome Diagnostics and Therapeutics Revenue Market Share by Country (2016-2026)
Figure 43. United States Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Exosome Diagnostics and Therapeutics Sales Market Share by Type (2016-2026)
Figure 47. Europe Exosome Diagnostics and Therapeutics Sales Market Share by Application (2016-2026)
Figure 48. Europe Exosome Diagnostics and Therapeutics Revenue Market Share by Country (2016-2026)
Figure 49. Germany Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Exosome Diagnostics and Therapeutics Sales Market Share by Type (2016-2026)
Figure 55. Asia-Pacific Exosome Diagnostics and Therapeutics Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Exosome Diagnostics and Therapeutics Revenue Market Share by Region (2016-2026)
Figure 57. China Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South Korea Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Exosome Diagnostics and Therapeutics Sales Market Share by Type (2016-2026)
Figure 64. South America Exosome Diagnostics and Therapeutics Sales Market Share by Application (2016-2026)
Figure 65. South America Exosome Diagnostics and Therapeutics Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East and Africa Exosome Diagnostics and Therapeutics Sales Market Share by Type (2016-2026)
Figure 69. Middle East and Africa Exosome Diagnostics and Therapeutics Sales Market Share by Application (2016-2026)
Figure 70. Middle East and Africa Exosome Diagnostics and Therapeutics Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Saudi Arabia Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. UAE Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source

---